Literature DB >> 31904824

Diagnosis of coronary microvascular dysfunction in the clinic.

Peter Ong1, Basmah Safdar2, Andreas Seitz1, Astrid Hubert1, John F Beltrame3, Eva Prescott4.   

Abstract

The coronary microcirculation plays a pivotal role in the regulation of coronary blood flow and cardiac metabolism. It can adapt to acute and chronic pathologic conditions such as coronary thrombosis or long-standing hypertension. Due to the fact that the coronary microcirculation cannot be visualized in human beings in vivo, its assessment remains challenging. Thus, the clinical importance of the coronary microcirculation is still often underestimated or even neglected. Depending on the clinical condition of the respective patient, several non-invasive (e.g. transthoracic Doppler-echocardiography assessing coronary flow velocity reserve, cardiac magnetic resonance imaging, positron emission tomography) and invasive methods (e.g. assessment of coronary flow reserve (CFR) and microvascular resistance (MVR) using adenosine, microvascular coronary spasm with acetylcholine) have been established for the assessment of coronary microvascular function. Individual patient characteristics, but certainly also local availability, methodical expertise and costs will influence which methods are being used for the diagnostic work-up (non-invasive and/or invasive assessment) in a patient with recurrent symptoms and suspected coronary microvascular dysfunction. Recently, the combined invasive assessment of coronary vasoconstrictor as well as vasodilator abnormalities has been titled interventional diagnostic procedure (IDP). It involves intracoronary acetylcholine testing for the detection of coronary spasm as well as CFR and MVR assessment in response to adenosine using a dedicated wire. Currently, the IDP represents the most comprehensive coronary vasomotor assessment. Studies using the IDP to better characterize the endotypes observed will hopefully facilitate development of tailored and effective treatments. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Coronary microvascular dysfunction; Diagnosis; Vasoconstriction; Vasodilatation

Mesh:

Year:  2020        PMID: 31904824     DOI: 10.1093/cvr/cvz339

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Coronary microvascular disease: the next frontier for Cardiovascular Research.

Authors:  Colin Berry; Dirk J Duncker
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

2.  Appropriate use criteria implementation with modified Haller index for predicting stress echocardiographic results and outcome in a population of patients with suspected coronary artery disease.

Authors:  Andrea Sonaglioni; Elisabetta Rigamonti; Gian Luigi Nicolosi; Michele Lombardo
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-07       Impact factor: 2.357

Review 3.  Small vessel coronary artery disease: How small can we go with myocardial revascularization?

Authors:  Maciej T Wybraniec; Paweł Bańka; Tomasz Bochenek; Tomasz Roleder; Katarzyna Mizia-Stec
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

Review 4.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Rocco A Montone; Massimiliano Camilli; Salvatore Carbone; Jagat Narula; Carl J Lavie; Giampaolo Niccoli; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2021-09-28       Impact factor: 24.094

5.  The myocardial flow reserve in patients with heart failure with preserved ejection fraction.

Authors:  Andrew V Mochula; Kristina V Kopeva; Alina N Maltseva; Elena V Grakova; Marina Gulya; Andrey V Smorgon; Anna Gusakova; Konstantin V Zavadovsky
Journal:  Heart Vessels       Date:  2022-09-01       Impact factor: 1.814

Review 6.  The Continuum of Invasive Techniques for the Assessment of Intermediate Coronary Lesions.

Authors:  Nicoleta-Monica Popa-Fotea; Alexandru Scafa-Udriste; Maria Dorobantu
Journal:  Diagnostics (Basel)       Date:  2022-06-18

Review 7.  Vascularisation of pluripotent stem cell-derived myocardium: biomechanical insights for physiological relevance in cardiac tissue engineering.

Authors:  Oisín King; Ilona Sunyovszki; Cesare M Terracciano
Journal:  Pflugers Arch       Date:  2021-04-14       Impact factor: 3.657

8.  Does chest shape influence exercise stress echocardiographic results in patients with suspected coronary artery disease?

Authors:  Andrea Sonaglioni; Gian Luigi Nicolosi; Elisabetta Rigamonti; Michele Lombardo; Gian Franco Gensini; Giuseppe Ambrosio
Journal:  Intern Emerg Med       Date:  2021-05-30       Impact factor: 3.397

Review 9.  Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris.

Authors:  Sascha Beck; Valeria Martínez Pereyra; Andreas Seitz; Johanna McChord; Astrid Hubert; Raffi Bekeredjian; Udo Sechtem; Peter Ong
Journal:  Eur Cardiol       Date:  2021-07-05

10.  Pharmacological and simulated exercise cardiac stress tests produce different ischemic signatures in high-resolution experimental mapping studies.

Authors:  Brian Zenger; Wilson W Good; Jake A Bergquist; Lindsay C Rupp; Maura Perez; Gregory J Stoddard; Vikas Sharma; Rob S MacLeod
Journal:  J Electrocardiol       Date:  2021-07-24       Impact factor: 1.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.